Patents by Inventor Susan Sullivan

Susan Sullivan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bioengineered vascular graft prostheses
    Publication number: 20060100717
    Abstract: The invention is directed to bioengineered graft prostheses prepared from cleaned tissue material derived from animal sources. The bioengineered graft prostheses of the invention are prepared using methods that preserve cell compatibility, strength, and bioremodelability of the processed tissue matrix. The bioengineered graft prostheses are used for implantation, repair, or use in a mammalian host.
    Type: Application
    Filed: November 23, 2005
    Publication date: May 11, 2006
    Applicant: Organogenesis, Inc.
    Inventors: Ginger Abraham, Susan Sullivan, James Murray
  • Preparation of pure human tumor necrosis factor and hybridomas producing monoclonal antibodies to human tumor necrosis factor
    Patent number: 4870163
    Abstract: Human TNF(LuKII) having a specific activity of at least 1.5.times.10.sup.5 units per milligram of total protein is produced by contacting a TNF-containing protein composition, which has been harvested from human cell lines of hematopoietic origin or recombinant origin, in separate adsorption stages with glass beads, lentil lectin bound to Sepharose, and procion red agarose, thereby selectively to adsorb TNF in each stage, while leaving some impurities unadsorbed, each contact stage being followed by contact of the adsorbent with an eluant thereby to obtain a solution of more highly purified TNF after each stage. The purified human TNF(LuKII) is used to produce monoclonal antibodies against TNF(LuKII) and such antibodies can be used to assay samples for the presence of TNF(LuKII).
    Type: Grant
    Filed: August 29, 1985
    Date of Patent: September 26, 1989
    Assignees: New York Blood Center, Inc., Sloan-Kettering Institute for Cancer Research
    Inventors: Berish Y. Rubin, Sylvia L. Anderson, Susan A. Sullivan, Lloyd J. Old, Barbara D. Williamson, Elizabeth C. Richards
  • Detection of the sensitivity of cells to the effects of tumor necrosis factor and lymphotoxin
    Patent number: 4770995
    Abstract: A process for predicting the sensitivity of cells, e.g., tumor cells, to the effects of tumor necrosis factor or lymphotoxin involving ascertaining the binding of the tumor necrosis factor or lymphotoxin to the cells, i.e., measuring the number of receptors on the cells.
    Type: Grant
    Filed: August 29, 1985
    Date of Patent: September 13, 1988
    Assignees: New York Blood Center, Inc, Sloan-Kettering Institute for Cancer Research
    Inventors: Berish Y. Rubin, Sylvia L. Anderson, Susan A. Sullivan, Lloyd J. Old, Barbara D. Williamson, Elizabeth C. Richards